MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
178 hedge funds and large institutions have $3.62B invested in MyoKardia, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 54
39% less call options, than puts
Call options by funds: $15.8M | Put options by funds: $26M
Holders
178
Holding in Top 10
9
Calls
$15.8M
Puts
$26M
Top Buyers
| 1 | +$74.7M | |
| 2 | +$63.3M | |
| 3 | +$20.6M | |
| 4 |
BlackRock
New York
|
+$18.9M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.7M |
Top Sellers
| 1 | -$64M | |
| 2 | -$55M | |
| 3 | -$14.9M | |
| 4 |
D.E. Shaw & Co
New York
|
-$14.9M |
| 5 |
HM
HealthCor Management
New York
|
-$14.7M |